A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Pfizer
AstraZeneca
AstraZeneca
Genmab
DL Analytics
PinkDx, Inc.
Leap Therapeutics, Inc.
Incyte Corporation
Leap Therapeutics, Inc.
Gradalis, Inc.
Aesculap AG
Precision Biologics, Inc
Revolution Medicines, Inc.
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
ZIWIG
Karyopharm Therapeutics Inc
Mabwell (Shanghai) Bioscience Co., Ltd.
DxTerity Diagnostics
Advaxis, Inc.
Power Life Sciences Inc.
Genmab
Kineta Inc.
Revolution Medicines, Inc.
Gradalis, Inc.
Revolution Medicines, Inc.
Exact Sciences Corporation
SpeciCare
Pfizer
CytoCore, Inc.
Novartis
Gynesonics
ImmunoFrontier, Inc.
Cook Group Incorporated
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Precision Therapeutics
Xoft, Inc.
Boston Scientific Corporation
Novartis
Astellas Pharma Inc
Takeda
Eli Lilly and Company
Sanofi
Amgen
Eli Lilly and Company